Journal Information

Most Often Read

512
Pharmacological treatment of COPD – New evidence
N. Pires, P. Pinto, N. Marçal, A.J. Ferreira, C. Rodrigues, C. Bárbara
Pulmonol.2019;25:90-6
512
Open access
443
Reference equations for the 6-minute walk distance in healthy Portuguese subjects 18–70 years old
M.J. Oliveira, R. Marçôa, J. Moutinho, P. Oliveira, I. Ladeira, R. Lima, M. Guimarães
Pulmonol.2019;25:83-9
443
Open access
443
Physiological and clinical characteristics of patients with COPD admitted to an inpatient pulmonary rehabilitation program: A real-life study
Roberto Maestri, Claudio Bruschi, Claudio Fracchia, Gian Domenico Pinna, Francesco Fanfulla, Nicolino Ambrosino
Pulmonol.2019;25:71-8
443
Open access
365
Hypersensitivity pneumonitis: Antigen diversity and disease implications
R. Nogueira, N. Melo, H. Novais e Bastos, N. Martins, L. Delgado, A. Morais, P. C. Mota
Pulmonol.2019;25:97-108
365
Open access
327
Intra-hospital mortality for community-acquired pneumonia in mainland Portugal between 2000 and 2009
F. Teixeira-Lopes, A. Cysneiros, A. Dias, V. Durão, C. Costa, F. Paula, M. Serrado, B. Nunes, A. Diniz, F. Froes
Pulmonol.2019;25:66-70
327
Open access
303
Differential risk factors for slowly and rapidly-growing nontuberculous mycobacteria: A retrospective cross-sectional study
A. Santos-Silva, F. Pereira, R. Gaio, R. Duarte
Pulmonol.2019;25:114-6
303
Open access
257
Benefits of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease and interstitial lung disease with the same dyspnea severity
P.I. Pedro, L. Maia Santos, C. Braço Forte, A. Dias, C. Cruz, F. Rodrigues
Pulmonol.2019;25:117-8
257
Open access
257
Hospital admissions in children with acute respiratory disease in Portugal
J. Borges, M. Valente Rosa, R.M. Fernandes, P.J. Nogueira, T. Bandeira
Pulmonol.2019;25:122-5
257
Open access
220
Subacute invasive aspergillosis in a patient with cystic fibrosis
E. Padrão, A. Amorim
Pulmonol.2019;25:126-7
220
Open access
218
Pulmonary nodules in a patient with Giant Cell Arteritis
D. Pinho dos Santos, J.P. Fonseca, V. Romão, J. Capelo, A. Carragoso
Pulmonol.2019;25:109-13
218
Open access
205
Legionnaire's-disease-associated meningoencephalitis: A case report
D. Grün, M.M. Unger, J. Kauffmann, V. Zimmer, K. Fassbender, M. Fousse
Pulmonol.2019;25:128-30
205
Open access
202
Cervical mediastinoscopy: Safety profile, feasibility and diagnostic accuracy in a decade in a single center
João Santos Silva, Ana Rita Costa, Paulo Calvinho
Pulmonol.2019;25:119-20
202
Open access
173
Resistance exercise training improves mucociliary clearance in subjects with COPD: A randomized clinical trial
B.S.A. Silva, D. Ramos, G.N. Bertolini, A.P.C.F. Freire, M.R. Leite, C.A. Camillo, L.A. Gobbo, E.M.C. Ramos
173
Open access
Available online 5 March 2019
172
Referral protocols to general pulmonology consultation: Yes we should
B. Ramos, C.C. Loureiro
Pulmonol.2019;25:121-2
172
Open access
142
Immunotherapy in Allergic Asthma – 5 year analysis: Is it a curative approach?
J. Coutinho Costa, J.N. Machado, C. Ferreira, J.M.R. Gama, T. Almeida, A.M. Arrobas
142
Open access
Available online 10 March 2019
97
Mapping Portuguese Research on Respiratory Diseases in Primary Care: A systematic review
B. Malheiro, P.M. Teixeira, L. Alves, J. Yaphe, J. Correia de Sousa
97
Open access
Available online 10 March 2019
81
Inflammatory prognostic biomarkers in advanced non-small cell lung cancer
D. Machado, C. Marques, M. Dias, S. Campainha, A. Barroso
81
Open access
Available online 30 March 2019
70
Why does it take so long? The reasons behind tuberculosis treatment delay in Portugal
I. Zão, A.I. Ribeiro, D. Apolinário, R. Duarte
70
Open access
Available online 29 March 2019
19
Quo Vadis…Pneumonia
Venceslau Hespanhol
Pulmonol.2019;25:65
19
Open access
Pulmonology

Subscribe to our newsletter

Are you a health professional able to prescribe or dispense drugs?

Cookies policy
To improve our services and products, we use cookies (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.